|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005953,
umls-concept:C0008838,
umls-concept:C0008976,
umls-concept:C0010583,
umls-concept:C0015133,
umls-concept:C0027651,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0183683,
umls-concept:C0205195,
umls-concept:C0231174,
umls-concept:C0344211,
umls-concept:C1171411,
umls-concept:C1274040,
umls-concept:C1317973,
umls-concept:C1518411,
umls-concept:C1521721,
umls-concept:C1522484
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-1-22
|
|
pubmed:abstractText |
To assess the impact on survival of high-dose chemotherapy with haematopoietic support in patients with high-volume, metastatic nonseminomatous germ cell tumours.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
pubmed-author:BironPierreP,
pubmed-author:BouzyJeannineJ,
pubmed-author:ChevreauChristineC,
pubmed-author:CulineStéphaneS,
pubmed-author:CuréHervéH,
pubmed-author:DrozJean-PierreJP,
pubmed-author:Genito-Urinary Group of the French Federation of Cancer Centers (GETUG),
pubmed-author:KerbratPierreP,
pubmed-author:KramarAndrewA,
pubmed-author:PényJeanJ,
pubmed-author:PicoJosé-LuisJL,
pubmed-author:ThéodoreChristineC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
739-46; discussion 747-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17084512-Adult,
pubmed-meshheading:17084512-Antineoplastic Agents,
pubmed-meshheading:17084512-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17084512-Bone Marrow Transplantation,
pubmed-meshheading:17084512-Cisplatin,
pubmed-meshheading:17084512-Combined Modality Therapy,
pubmed-meshheading:17084512-Cyclophosphamide,
pubmed-meshheading:17084512-Etoposide,
pubmed-meshheading:17084512-Follow-Up Studies,
pubmed-meshheading:17084512-Humans,
pubmed-meshheading:17084512-Male,
pubmed-meshheading:17084512-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:17084512-Testicular Neoplasms,
pubmed-meshheading:17084512-Treatment Failure
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
|
|
pubmed:affiliation |
Centre Léon Bérard, Lyon, France.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
